Furthermore adipose tissue can be harvested in relatively large quantities (from 100 ml to several litres) using a low-morbidity liposuction procedure that was performed in 341,144 elective cosmetic procedures in the United States in 2004 [7] . Moreover, cultured populations of ASCs can be expanded rapidly (more than 10-fold within 1 week), and over long periods in culture [6] .
A [8] [9] [10] .
number of investigators have published data suggesting that ASCs have the ability to differentiate into cells that exhibit features of the cardiomyocyte in vivo. To understand the process of ASCs differentiating into cardiomyocytes, various in vitro experiments have been performed to determine which cell population has the potential to become cardiomyocytes, and to elucidate which factors and techniques influence this differentiation
5-azacytidine (5-aza) , a DNA methyltransferase inhibitor, was the first agent used for cardiomyogenic differentiation of bone marrow stem cells (BMSCs) as there have been many studies using this approach [11] . These studies have reported successful transformation of rabbit or mouse, but not human ASCs (hASCs) into contractile cardiomyocyte-like cells [8, 12, 13] . Repeated exposure to 5-aza inhibited human cell growth, and caused apoptosis, limiting clinical application [13] . [9, 10, [14] [15] [16] , as well as co-culture with cardiomyocytes [17] . BMSCs have shown clear evidence that direct cell-cell interaction with cardiomyocytes can induce stem cells to differentiate into a cardiac lineage [17] [18] [19] [20] [21] . Recently, ASCs were shown to differentiate towards a cardiac lineage expressing cardiac markers in co-culture with cardiomyocytes [22] .
Because of these limitations with 5-aza, researchers have sought other methods for cardiomyogenic differentiation, modified culture media (including growth factors), cardiomyocyte extracts and histone deacetylase inhibitor such as trichostatin A (TSA) used for that purpose in various experiments
Although numerous methods including 5-aza, modified culture media, TSA and co-culture systems have been examined for their capacity to induce cardiomyogenic differentiation, the results are inconsistent and ineffective for cardiac tissue engineering. The aim of this study was to optimize the methods and culture timing for cardiomyogenic differentiation of ASCs. We compared the capacities of three different cardiomyogenic differentiation methods using ASC in vitro and developed a co-culture system.
Materials and methods

Primary culture of human adipose-derived stem cells
ASCs were isolated from freshly excised human subcutaneous adipose tissue (donor age between 43 to 52 years) according to the method described by Zuk et al. [23] [8] .
5-azacytidine treatment
Modified cardiomyogenic medium
For cardiomyogenic differentiation we modified culture medium from Shim et al. [19] and Planat-Bénard et al. [10] . Fig. S2 . This CD marker profile is consistent with previous reports for ASC [23] . (Fig. 1B) .
The cells were characterized by colony forming assay and stro-1 staining. After 2 weeks of culture in 20% FCS, about 8% of ASCs formed colony. ASCs cultured in normal condition (about 70% confluence in 10% FCS) showed stro-1 positive staining (Fig. S3).
Cardiomyogenic treatment of ASC with 5-azacytidine or modified culture medium
For cardiomyogenic differentiation, ASCs were treated with 5-aza for 24 hrs or continuously with MCM. Both 5-aza and MCM treated cells were cultured for 3 weeks. Non-treated ASCs acted as a control (at the same passage). Cells treated by 5-aza for 24 hrs were not really changed in their shape (Fig. S1B). Few cells died after 5-aza treatment because of their cytotoxicity (data not shown). But cells proliferated afterward. In contrary, the shapes of cells cultured in MCM were changed to polygonal or rod shape (Fig. S1C). Cardiac actin and TropT mRNA were detected in ASCs at 1, 2 and 3 weeks by real-time RT-PCR (Fig. 1). 5-aza caused a time-depend-
5-aza and MCM treated ASCs were double stained ( Fig. 2) with Nkx2.5 (cardiac transcription factor; nuclei) and ␣-actin (cardiac contractile protein; cytoplasm) ( Fig. 2A-C) , or with Nkx2. 5 and TropI (troponin-inhibitory subunit; cytoplasm) (Fig. 2D-F) . In the control group, Nkx2.5 was detected in some ASCs but double staining for Nkx2.5 and ␣-actin or TropI was rare ( Fig. 2A, D) (Fig. 4) . 
Primary neonatal rat cardiomyocyte culture
Co-culture system with insert
ASCs were subjected to indirect co-culture with neonatal rat cardiomyocytes suspended in a culture well insert for up to 3 weeks (Fig. S4) (Fig. 6) . Immunocytochemistry revealed expression of cardiac transcription (Fig. 6A-E) . MyoD was not expressed in ASCs (Fig. 6F) . 
Fig. 2 Immunocytochemistry for ASCs (A, D), 5-aza treated ASCs (B, E), ASCs cultured in MCM (C, F) after 3 weeks. Images show expression of Nkx2.5 (green) and ␣-actin (red) (A-C); Nkx2.5 (green) and TropI (red) (D-F). Scale bar ϭ 100 m.
factors, GATA4 and Nkx2.5, and contractile proteins, ␣-actin, TropI and cMHC in CM-DiI labelled ASCs
Calcium imaging
Gap junctions between ASC and cardiomyocyte
To confirm the presence of functional gap junction, ASCs labelled by CM-DiI were co-cultured with rat cardiomyocytes labelled by calcein AM (Fig. 7) [11, 26] and rabbit ASCs has been reported previously [8] , however, we were not able to succeed with this method for hASCs. Others have also failed to reproduce cardiac differentiation from MSC using 5-aza. Only passage 4 (P4) but not P1 and P8 rat BMSCs showed expression of cardiac-specific markers including Nkx2.5 and TropI [27] . Rat BMSCs could not be expanded extensively in vitro nor could they be induced to differentiate into cardiomyocyte-like cells using various concentrations of 5-aza with single or repeated treatment [28] . Moreover, spontaneously and synchronously pulsating cardiomyocyte-like cells were not observed after 8 weeks in culture. In addition, repeated exposure of 5-aza to ASCs significantly inhibited cell growth [13] . Lee [13] . In our study, expression of cardiac actin and TropT mRNA were actually reduced more than 5-fold from control levels (Fig. 1) (Fig. S6) As an alternative epigenetic modification, the histone deacetylase inhibitor TSA has been used for cardiomyogenic differentiation of embryonic stem cells [14, 15, 29] . Histone deacetylases regulate gene expression patterns by affecting chromatin structure [14] . In addition, they deacetylate lysine residues and induce compaction of chromatin, reducing the access of transcription factors to nearby promoters and thereby resulting in gene silencing [30] . TSA promotes the differentiation of embryonic stem cells into cardiac myocytes [14] but inhibits the differentiation of adipocytes [31] or oligodendrocytes [32] . In the skeletal muscle cell lineage, TSA either augments or inhibits the differentiation depending on the developmental stage [33] . We The third and most effective approach (Fig. S7) In this study, we attempted to optimize the ratio of cell numbers and the relative position of the co-cultured cells. A 1:10 ratio caused 2-to 3-fold increase in cardiac actin compared with a 1:5 ratio, which was used in another study [22] . Once the ratio and the position was optimized, ASCs were co-cultured with cardiomyocytes for 3, 5, 7, 14, 21 days to examine expression of cardiac actin mRNA (Fig. 5) . Surprisingly 
Discussion
We have shown here how to induce cardiomyogenic differentiation of hASCs by treatment with epigenetic modifiers (5-aza, TSA), by an inducing culture medium formulation and by a co-culture system using neonatal rat cardiomyocytes. The ability of 5-aza to induce cardiomyogenic gene and protein expression in BMSCs (also frequently referred to as mesenchymal stem cells)
et al. also failed to observe the conversion of hASCs into beating cardiomyocyte-like cells (they neither formed myotubes nor produced spontaneously beating cells after 8 weeks)
. Although some ASCs treated by 5-aza expressed Nkx2.5, TropI and ␣-actin, the number of cells expressing both Nkx2.5 and ␣-actin or TropI was only slightly increased (the number of cells expressing two cardiac markers 9.2% versus 0.2% in controls, Fig. 2B, E) and we did not find any contracting cells after 5-aza treatment. Furthermore, the proliferation capacity of 5-aza-treated ASCs was decreased after 3 weeks of treatment (44.2% versus 80.4% in control). The reason for resistance of ASC to induction of differentiation by 5-aza was further investigated by examining the DNA methylation
Fig. 3 Real-time RT-PCR analysis of cardiac actin mRNA in hASCs after trichostatin A treatment for 24 hrs, and cultured in control medium or continuously for 1, 2 and 3 weeks (A). ASCs also treated by TSA continuously for 1 week were cultured in control medium or CCM for 2 weeks (B). GAPDH was used as internal control. Bar graphs indicate fold change of mRNA compared with ASCs (dotted line). Results are shown as mean Ϯ S.E.M. (n ϭ 3). *P Ͻ 0.05 versus other groups profile of a 2.5-kb region in the promoter of eight cardiac markers in ASCs, as part of a larger methylated DNA immunoprecipitation microarray-based study (A.L. Sørensen, A.H. Reiner and PC; manuscript in preparation)
